Home›Stock Screener›Cresanto Global

Cresanto Global Share Price Today | Stock Price & Cresanto Global Share Screener

CRESANTO Pharmaceuticals
Live Share Price BSE
₹5.37
▲ 0.00 (0.00%)
2026-09-21 00:00:00

As of September 21, 2026, the live Cresanto Global share price (BSE: CRESANTO) is ₹5.37, unchanged from the previous close, with shares trading between ₹5.37 and ₹5.37 in today's trading session, and a 52-week range of ₹3.83–₹5.37. Check CRESANTO price range for the annual price range and momentum. Use the Cresanto Global stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Cresanto Global opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Cresanto Global Market Cap ₹1.90 Cr.
CRESANTO P/E Ratio (TTM) -14.77
Cresanto Global P/B Ratio -0.70
EPS (TTM) ₹-0.42
Dividend Yield -
Debt to Equity -
CRESANTO 52 Week High ₹5.37
Cresanto Global 52 Week Low ₹3.83
Operating Margin -5.00%
Profit Margin -
CRESANTO Revenue (TTM) ₹1.00
EBITDA -
Net Income -
Total Assets -
Total Equity ₹-3.00

Cresanto Global Share Price Chart

Track the current stock price of Cresanto Global with an interactive chart. Analyse CRESANTO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Cresanto Global stock quote in one place.

The quote of ₹5.37 sits between the 52-week low of ₹3.83 and the 52-week high of ₹5.37.

Cresanto Global Company Profile - Fundamental Screener

Screen Cresanto Global company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CRESANTO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE741C01017.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE741C01017

Cresanto Global Balance Sheet Screener

Screen CRESANTO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹0.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 0 0 0 0 0 0 0 0 0 0
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 2 2 2 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity -3 -2 -2 -2 -2 -2 -2 -2 -2 -2
Share Capital 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus -7 -7 -7 -6 -6 -6 -6 -6 -6 -6

Cresanto Global Income Statement Screener - Profit & Revenue Analysis

Screen Cresanto Global income statement and profit fundamentals. Analyze CRESANTO quarterly results. Cresanto Global reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹1 and net profit was ₹0, equal to earnings per unit of ₹-0.30, at an operating margin of -5%.

In that period expenses were ₹1, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹1 and net profit of ₹0.

Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 1 1 0 0 0 0 0 0 0 0 0 0
Expenses 1 1 0 0 0 0 0 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit % -5.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 0 0 0 0 0
EPS -0.30 -0.42 -0.24 -0.40 -0.19 -0.16 -0.13 -0.13 -0.13 -0.12 -0.09 -0.04

Cresanto Global Cash Flow Screener - Liquidity Fundamentals

Screen CRESANTO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹1.

Over the same period, investing activities provided ₹1 and financing activities provided ₹0.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities -1 0 0 -2 0 0 0 0 0 0
Investing Activities 1 0 0 2 0 0 0 0 0 0

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Cresanto Global Shareholding Pattern Screener

See Cresanto Global shareholding pattern with promoter, FII, and DII holdings. Check Cresanto Global promoter holding and ownership changes for CRESANTO on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 32.27%, foreign institutions 0.00%, domestic institutions 0.96% and the public 43.93%, spread across 1,490 shareholders.

The shareholder count was 1,490 in 2025-Mar, compared with 1,490 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec

Promoter Holding

Promoter Holding 32.27% 32.27% 32.27% 32.27% 28.36% 28.36% 28.36% 28.36%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 43.93% 43.93% 44.15% 44.15% 47.80% 47.90% 47.90% 47.86%
Other Holding 22.83% 22.83% 22.62% 22.62% 22.88% 22.78% 22.78% 22.82%
Shareholder Count 1,490 1,490 1,482 1,482 1,504 1,503 1,497 1,494

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Cresanto Global. Cresanto Global dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Cresanto Global.

Cresanto Global Stock Index Membership - Nifty & Sensex

See which indices include Cresanto Global stock. Check CRESANTO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Cresanto Global is not part of any tracked indices.
Only major market indices are tracked in our system.

Cresanto Global Market Events Screener - Corporate Actions

Get Cresanto Global corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Cresanto Global stock events that may affect CRESANTO share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Annual General Meeting dated .

It is followed by Annual General Meeting dated and Quarterly Result Announcement dated February 4, 2026.

Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 0.00%
Annual General Meeting NA 4.80%
2026-02-04 2026-02-04 Quarterly Result Announcement NA 0.00%
2025-11-05 2025-11-05 Quarterly Result Announcement NA 0.00%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.00%
2025-05-22 2025-05-22 Quarterly Result Announcement NA 0.00%
2025-04-21 2025-04-21 Extraordinary General Meeting NA 0.00%
2025-03-25 2025-03-25 Change Of Name NA 0.00%
2025-01-27 2025-01-27 Quarterly Result Announcement NA 0.00%
2024-11-06 2024-11-06 Quarterly Result Announcement NA 0.00%

Cresanto Global Competitors Screener - Peer Stocks Comparison

Screen CRESANTO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 421,899 38.94 54,729 9.71% 10,980 49.38
Divis Laboratories 159,640 65.35 9,712 18.67% 2,191 40.11
Torrent Pharmaceuticals 142,618 63.57 11,539 6.99% 1,911 45.74
Lupin 104,913 22.73 22,910 13.74% 3,306 52.63
Dr Reddys Laboratories 104,604 19.63 33,741 16.73% 5,725 43.17
Cipla 98,694 22.38 28,410 7.12% 5,291 26.47
Zydus Life Science 86,597 17.83 23,511 18.55% 4,615 37.77
Mankind Pharma 79,564 45.78 12,744 20.90% 2,007 32.45
Aurobindo Pharma 74,267 21.52 32,346 9.43% 3,484 57.83
Alkem Laboratories 61,510 25.95 13,458 3.70% 2,216 33.49

Cresanto Global Company Announcements - News & Reports Screener

Screen CRESANTO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated February 23, 2026.

The next most recent announcements are dated February 6, 2026 and February 5, 2026.

Date Update Actions
2026-02-23 Board Meeting Outcome for Meeting Held On 23Rd February 2026 -
2026-02-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-05 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-02-04 Results For The December Quarter 2025 -
2026-02-04 Board Meeting Outcome for Meeting Held On 04Th February 2026 -
2026-01-31 Board Meeting Intimation for Approval For Un-Audited Financials For The December 2025 Quarter. -
2026-01-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-27 Closure of Trading Window -
2025-11-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-05 Un-Audited Results For Q2 Ended 30Th September 2025 -
2025-11-05 Board Meeting Outcome for Meeting Schedule On 05Th November 2025 -
2025-10-29 Board Meeting Intimation for Meeting Schedule On 05Th November 2025 -
2025-10-28 Intimation Under Reg. 30 For SEBI (LODR) Regulations 2015 For Filing Of Petition U/S. 66 Of The Companies Act 2013 -
2025-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-27 Closure of Trading Window -
2025-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-09-03 Reg. 34 (1) Annual Report. -
2025-09-03 Fixes Book Closure For The 33Rd Annual General Meeting -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹5.37, within a 52-week range of ₹3.83 to ₹5.37. The P/E ratio is -14.77 and the P/B ratio is -0.70, with earnings per unit of ₹-0.42. Market capitalisation stands at ₹1.90 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.